210 related articles for article (PubMed ID: 26598538)
1. Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?
Postel-Vinay S; Boursin Y; Massard C; Hollebecque A; Ileana E; Chiron M; Jung J; Lee JS; Balogh Z; Adam J; Vielh P; Angevin E; Lacroix L; Soria JC
Ann Oncol; 2016 Feb; 27(2):344-52. PubMed ID: 26598538
[TBL] [Abstract][Full Text] [Related]
2. Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel.
Dufresne A; Attignon V; Ferrari A; Tonon L; Boyault S; Tabone-Eglinger S; Cassier P; Trédan O; Corradini N; Vinceneux A; Swalduz A; Viari A; Chabaud S; Pérol D; Blay JY; Saintigny P
Cancer Med; 2024 Apr; 13(7):e7115. PubMed ID: 38553950
[TBL] [Abstract][Full Text] [Related]
3. Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Bertucci F; Gonçalves A; Guille A; Adelaïde J; Garnier S; Carbuccia N; Billon E; Finetti P; Sfumato P; Monneur A; Pécheux C; Khran M; Brunelle S; Mescam L; Thomassin-Piana J; Poizat F; Charafe-Jauffret E; Turrini O; Lambaudie E; Provansal M; Extra JM; Madroszyk A; Gilabert M; Sabatier R; Vicier C; Mamessier E; Chabannon C; Pakradouni J; Viens P; André F; Gravis G; Popovici C; Birnbaum D; Chaffanet M
Genome Med; 2021 May; 13(1):87. PubMed ID: 34006291
[TBL] [Abstract][Full Text] [Related]
4. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
5. Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.
Ramkissoon SH; Bandopadhayay P; Hwang J; Ramkissoon LA; Greenwald NF; Schumacher SE; O'Rourke R; Pinches N; Ho P; Malkin H; Sinai C; Filbin M; Plant A; Bi WL; Chang MS; Yang E; Wright KD; Manley PE; Ducar M; Alexandrescu S; Lidov H; Delalle I; Goumnerova LC; Church AJ; Janeway KA; Harris MH; MacConaill LE; Folkerth RD; Lindeman NI; Stiles CD; Kieran MW; Ligon AH; Santagata S; Dubuc AM; Chi SN; Beroukhim R; Ligon KL
Neuro Oncol; 2017 Jul; 19(7):986-996. PubMed ID: 28104717
[TBL] [Abstract][Full Text] [Related]
6. Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors.
Koeppel F; Bobard A; Lefebvre C; Pedrero M; Deloger M; Boursin Y; Richon C; Chen-Min-Tao R; Robert G; Meurice G; Rouleau E; Michiels S; Massard C; Scoazec JY; Solary E; Soria JC; André F; Lacroix L
Cancer J; 2018; 24(4):153-162. PubMed ID: 30119077
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of extensive molecular profiling in advanced cancer patients.
Cousin S; Grellety T; Toulmonde M; Auzanneau C; Khalifa E; Laizet Y; Tran K; Le Moulec S; Floquet A; Garbay D; Robert J; Hostein I; Soubeyran I; Italiano A
J Hematol Oncol; 2017 Feb; 10(1):45. PubMed ID: 28179005
[TBL] [Abstract][Full Text] [Related]
8. CoNVEX: copy number variation estimation in exome sequencing data using HMM.
Amarasinghe KC; Li J; Halgamuge SK
BMC Bioinformatics; 2013; 14 Suppl 2(Suppl 2):S2. PubMed ID: 23368785
[TBL] [Abstract][Full Text] [Related]
9. Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.
Shimoda Y; Nagashima T; Urakami K; Tanabe T; Saito J; Naruoka A; Serizawa M; Mochizuki T; Ohshima K; Ohnami S; Ohnami S; Kusuhara M; Yamaguchi K
Biomed Res; 2016; 37(6):367-379. PubMed ID: 28003584
[TBL] [Abstract][Full Text] [Related]
10. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
11. The genetic landscape of infantile spasms.
Michaud JL; Lachance M; Hamdan FF; Carmant L; Lortie A; Diadori P; Major P; Meijer IA; Lemyre E; Cossette P; Mefford HC; Rouleau GA; Rossignol E
Hum Mol Genet; 2014 Sep; 23(18):4846-58. PubMed ID: 24781210
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
Park H; Cho SY; Kim H; Na D; Han JY; Chae J; Park C; Park OK; Min S; Kang J; Choi B; Min J; Kwon JY; Suh YS; Kong SH; Lee HJ; Liu ET; Kim JI; Kim S; Yang HK; Lee C
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12492-7. PubMed ID: 26401016
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials.
Martin-Romano P; Colmet-Daage L; Morel D; Baldini C; Verlingue L; Bahleda R; Gazzah A; Champiat S; Varga A; Michot JM; Ngo-Camus M; Nicotra C; Marabelle A; Soria JC; Rouleau E; Lacroix L; Hollebecque A; Massard C; Postel-Vinay S
Eur J Cancer; 2022 Sep; 173():133-145. PubMed ID: 35872509
[TBL] [Abstract][Full Text] [Related]
14. Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers.
Chua EW; Cree S; Barclay ML; Doudney K; Lehnert K; Aitchison A; Kennedy MA
Pharmacogenomics J; 2015 Oct; 15(5):414-21. PubMed ID: 25752523
[TBL] [Abstract][Full Text] [Related]
15. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
[TBL] [Abstract][Full Text] [Related]
16. Whole exome sequencing reveals copy number variants in individuals with disorders of sex development.
Sreenivasan R; Bell K; van den Bergen J; Robevska G; Belluoccio D; Dahiya R; Leong GM; Dulon J; Touraine P; Tucker EJ; Ayers K; Sinclair A
Mol Cell Endocrinol; 2022 Apr; 546():111570. PubMed ID: 35051551
[TBL] [Abstract][Full Text] [Related]
17. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families.
Timms AE; Dorschner MO; Wechsler J; Choi KY; Kirkwood R; Girirajan S; Baker C; Eichler EE; Korvatska O; Roche KW; Horwitz MS; Tsuang DW
JAMA Psychiatry; 2013 Jun; 70(6):582-90. PubMed ID: 23553203
[TBL] [Abstract][Full Text] [Related]
18. Genomic testing for copy number and single nucleotide variants in spermatogenic failure.
Hardy J; Pollock N; Gingrich T; Sweet P; Ramesh A; Kuong J; Basar A; Jiang H; Hwang K; Vukina J; Jaffe T; Olszewska M; Kurpisz M; Yatsenko AN
J Assist Reprod Genet; 2022 Sep; 39(9):2103-2114. PubMed ID: 35849255
[TBL] [Abstract][Full Text] [Related]
19. Application of whole-exome sequencing for detecting copy number variants in CMT1A/HNPP.
Jo HY; Park MH; Woo HM; Han MH; Kim BY; Choi BO; Chung KW; Koo SK
Clin Genet; 2016 Aug; 90(2):177-81. PubMed ID: 26662885
[TBL] [Abstract][Full Text] [Related]
20. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
